The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 182,395 | 26,666 | SH | DFND | 1 | 26,666 | 0 | 0 | |
SYNLOGIC INC | COM | 87166L100 | 88,540 | 205,906 | SH | DFND | 1 | 205,906 | 0 | 0 | |
CASTLE BIOSCIENCES INC | COM | 14843C105 | 461,349 | 33,626 | SH | DFND | 1 | 33,626 | 0 | 0 |